Skip to main content

Table 2 Demographic and clinical characteristics

From: Impact on healthcare resource utilization of multiple sclerosis in Spain

 

EDSS 0–3.5

EDSS 4.0–9.5

Total

p-value

N = 152

N = 70

N = 222

 

Geographic regions in Spain, %

 Asturias

30.9

22.9

28.4

0,587

 Catalonia

69.1

77.1

71.6

0,827

Age, years, mean (SD)

42.5 (11.5)

52.2 (12.2)

45.5 (12.5)

<0.001

Gender, female, N (%)

68.4

65.7

64.4

0.292

Time since diagnostic, years, mean (SD)

10.5 (7.6)

19.8 (10.2)

13.4 (9.5)

<0.001

MS type, %

 RRMS

74.3

35.7

62.2

<0.001

 SPMS

13.8

50.0

25.2

<0.001

 PPMS

7.2

14.3

9.5

0.009

 CIS

4.6

0.0

3.2

<0.001

Relapses during follow-up

 Number of relapses, mean (SD)

0.4 (0.6)

1.2 (1.0)

0.7 (0.9)

<0.001

Proportion of population, N (%)

  ≥ 1

36.8

67.1

46.4

<0.001

 1

29.6

18.6

26.1

0.008

 2

6.6

40.0

17.1

<0.001

 3

0.7

8.6

3.2

0.790

Comorbidity, mean (SD)

 Number of comorbidities

4.5 (2.7)

6.0 (3.3)

5.0 (3.0)

0.001

 Charlson Index

0.7 (0.6)

1.0 (0.7)

0.8 (0.6)

0.005

 RUBs, mean

2.9 (0.8)

3.2 (0.7)

3.0 (0.8)

0.003

Proportion of population, N (%)

 1 (healthy o very low morbidity)

3.3

0.0

2.3

<0.001

 2 (low morbidity)

25.7

14.3

22.1

0.038

 3 (moderate morbidity)

52.0

54.3

52.7

0.873

 4 (high morbidity)

18.4

28.6

21.6

0.041

 5 (very high morbidity)

0.7

2.9

1.4

0.031

  1. CIS clinically isolated syndrome, EDSS expanded disability status scale, MS multiple sclerosis, PPMS primary progressive MS, RRMS relapsing remitting MS, RUBs resource utilization bands, SD standard deviation, SPMS secondary-progressive MS